Related Experiment Video
Updated: Jun 27, 2026

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
[Galectins in squamous cell carcinomas of the head and neck cancers]
1Karlova Univerzita, 1. lékarská fakulta, Anatomický ústav, Praha.
Abstract:
Cancers of head and neck represents about 5% of all tumors. 80 to 90% of these tumors are constituted of squamous cell carcinomas. Despite a rapid progress in diagnostics and therapy the overall 5-year survival of this type of cancer is among the lowest of the major cancer types. This unfavourable situation needs the extensive research to found new markers to better characterize biological behavior of tumors as a rational background for more sophisticated therapeutic modalities. Among the most promising markers are endogenous lectins called galectins and their ligands. Especially galectin-1, -3 and -7 play a key role in pathology of squamous cell carcinomas.
Insights
Head and neck squamous cell carcinomas have poor survival rates, necessitating new biomarkers. Research highlights endogenous lectins, specifically galectins-1, -3, and -7, as key players in tumor pathology.
Area of Science:
- Oncology
- Biochemistry
Context:
- Head and neck cancers (HNCs) constitute 5% of all tumors.
- Squamous cell carcinomas (SCCs) account for 80-90% of HNCs.
- HNCs exhibit low 5-year survival rates despite diagnostic and therapeutic advancements.
Purpose:
- To identify novel biomarkers for characterizing tumor behavior in HNCs.
- To explore the role of endogenous lectins (galectins) and their ligands in HNC pathology.
Summary:
- Galectins, a family of endogenous lectins, are implicated in cancer development.
- Galectin-1, -3, and -7 are particularly significant in the pathology of squamous cell carcinomas.
- These galectins show promise as markers for understanding HNC biological behavior.
Impact:
- Findings may lead to improved diagnostic and therapeutic strategies for HNCs.
- Identification of galectins as key markers could facilitate the development of targeted therapies.
- Further research into galectins can enhance characterization of tumor biology for better patient outcomes.
Related Concept Videos
Selectins
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.

